EVLO / Evelo Biosciences, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Evelo Biosciences, Inc.
US ˙ OTCPK ˙ US2997342025

Deler fremragende 18,982,837 shares
Insideraktier11.264.905 shares
Insider ejerskab59,34 %
Total Insiders42
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
8084 out of 10951

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
7936 out of 10791

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Evelo Biosciences, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Noubar Afeyan Director, 10% Owner - [D] [10%] 4.125.461 4.977.588
Alexandria Venture Investments, LLC 10% Owner - [10%] 594.443 29.722
Juan Andres 15.690
Mark Bodmer CSO, President of R&D - [O] 25.732 25.732
Stephen J Carriere Principal Accounting Officer - [O] 203 10
Daniel Char 80.000
Lord Ara Darzi Director - [D] 342.465 17.123
David R Epstein Director - [D] 93.932 4.697
Flagship Pioneering Fund VII General Partner LLC 10% Owner - [10%] 13.698.630 4.977.588
Flagship V VentureLabs Rx Fund, L.P. 10% Owner - [10%] 18.233.403 911.670
Flagship VentureLabs IV, LLC 10% Owner - [10%] 18.233.403 911.670
Flagship VentureLabs V LLC 10% Owner - [10%] 18.233.403 911.670
Flagship VentureLabs V Manager LLC 10% Owner - [10%] 6.624.607 331.230
Flagship Ventures Fund IV General Partner LLC 10% Owner - [10%] 4.977.588 4.977.588
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Flagship Ventures Fund IV, L.P. 10% Owner - [10%] 4.125.461 4.977.588
Flagship Ventures Fund IV-Rx, L.P. 10% Owner - [10%] 4.125.461 684.932
Flagship Ventures Fund V General Partner LLC 10% Owner - [10%] 18.233.403 911.670
Flagship Ventures Fund V, L.P. 10% Owner - [10%] 18.233.403 911.670
Flagship Ventures Management, Inc. 10% Owner - [10%] 6.624.607 4.977.588
Flagship Ventures Opportunities Fund I General Partner LLC 10% Owner - [10%] 4.125.461 684.932
Flagship Ventures Opportunities Fund I, L.P. 10% Owner - [10%] 4.125.461 684.932
Simba Gill President & CEO, Director - [D] [O] 17.758 17.758
Neil Graham 150.000
Jose-Carlos Gutierrez-Ramos Director - [D] 10.000 500
Technology Finance Corp Horizon 10% Owner - [10%] 4.329.004 4.329.004
Edwin M Jr Kania 10% Owner - [10%] 18.233.403 911.670
Xiaoli Jacqueline Liu Principal Accounting Officer - [O] 0 0
Kyriazi Theo Melas 15.690
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Duncan McHale Chief Medical Officer - [O] 16.984 16.984
McInnes Iain B. 35.000
Nutritional Health Disruptive Innovation Fund, L.P. 10% Owner - [10%] 18.233.403 911.670
Nutritional Health LTP Fund General Partner LLC 10% Owner - [10%] 4.125.461 4.977.588
Nutritional Health LTP Fund, L.P. 10% Owner - [10%] 4.125.461 4.977.588
Nutritional Health Side Fund, L.P. 10% Owner - [10%] 18.233.403 911.670
David P Perry 15.690
Plinio Mark D. Chief Commercial Officer - [O] 3.750 188
Jonathan Poole 48.000
Luca Scavo 60.000
Nancy A Simonian 15.690
Marella Thorell Chief Financial Officer - [O] 22.259 22.259
Tonya Williams 40.000
Zung Jonathan B. 115.000

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i EVLO / Evelo Biosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-07-11 Flagship Ventures Fund IV General Partner LLC 3.246.753 2,3100 3.246.753 2,3100 7.499.999 35 13.3100 35.714.283 476,19
2023-07-11 Flagship Ventures Fund IV General Partner LLC 1.082.251 2,3100 1.082.251 2,3100 2.500.000
2023-07-11 Flagship Ventures Fund IV General Partner LLC 1.082.251 2,3100 1.082.251 2,3100 2.500.000
2022-05-27 Flagship Ventures Fund IV General Partner LLC 4.383.561 1,4600 219.178 29,2000 6.399.999
2022-05-27 Flagship Ventures Fund IV General Partner LLC 1.095.890 1,4600 54.794 29,2000 1.599.999
2022-05-27 Flagship Ventures Fund IV General Partner LLC 1.369.863 1,4600 68.493 29,2000 2.000.000
2022-05-27 Flagship Ventures Fund IV General Partner LLC 6.849.315 1,4600 342.466 29,2000 10.000.000
2022-05-27 Flagship Ventures Fund IV General Partner LLC 13.698.630 1,4600 684.932 29,2000 20.000.000
2022-05-27 Darzi Lord Ara 342.465 1,4600 17.123 29,2000 499.999

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EVLO / Evelo Biosciences, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i EVLO / Evelo Biosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-01-23 CARRIERE STEPHEN J 151 1,0604 8 21,2080 160 291 0.3048 -158 -98,67
2020-12-01 Liu Xiaoli Jacqueline 3.000 5,1700 150 103,4000 15.510

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

EVLO / Evelo Biosciences, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2023-11-08 2023-11-08 4 Thorell Marella EVLO Common Stock S - Sale D 0,3300 -1.811 -1 22.259
2023-11-08 2023-11-07 4 Thorell Marella EVLO Common Stock M - Exercise D 6.500 24.070
2023-11-08 2023-11-08 4 GILL SIMBA EVLO Common Stock S - Sale D 0,3300 -172 -0 17.758
2023-11-08 2023-11-07 4 GILL SIMBA EVLO Common Stock M - Exercise D 1.172 17.930
2023-11-08 2023-11-08 4 McHale Duncan EVLO Common Stock S - Sale D 0,3300 -3.103 -1 16.984
2023-11-08 2023-11-07 4 McHale Duncan EVLO Common Stock M - Exercise D 6.500 20.087
2023-11-08 2023-11-08 4 Bodmer Mark EVLO Common Stock S - Sale D 0,3300 -3.163 -1 25.732
2023-11-08 2023-11-07 4 Bodmer Mark EVLO Common Stock M - Exercise D 6.625 28.895
2023-11-03 2023-11-02 4 Bodmer Mark EVLO Common Stock S - Sale D 0,3300 -6.854 -2 22.270
2023-11-03 2023-11-01 4 Bodmer Mark EVLO Common Stock M - Exercise D 12.500 29.124
2023-11-03 2023-11-02 4 Thorell Marella EVLO Common Stock S - Sale D 0,3300 -3.999 -1 17.570
2023-11-03 2023-11-01 4 Thorell Marella EVLO Common Stock M - Exercise D 12.500 21.569
2023-11-03 2023-11-02 4 McHale Duncan EVLO Common Stock S - Sale D 0,3300 -6.854 -2 13.587
2023-11-03 2023-11-01 4 McHale Duncan EVLO Common Stock M - Exercise D 12.500 20.441
2023-09-29 2023-09-28 4 GILL SIMBA EVLO Common Stock S - Sale D 3,9400 -1.996 -8 16.758
2023-09-29 2023-09-27 4 GILL SIMBA EVLO Common Stock M - Exercise D 15.000 18.754
2023-08-09 2023-08-08 4 Bodmer Mark EVLO Common Stock S - Sale D 9,5100 -3.128 -30 16.624
2023-08-09 2023-08-07 4 Bodmer Mark EVLO Common Stock M - Exercise D 6.625 19.752
2023-08-09 2023-08-08 4 McHale Duncan EVLO Common Stock S - Sale D 9,5100 -3.434 -33 7.941
2023-08-09 2023-08-07 4 McHale Duncan EVLO Common Stock M - Exercise D 6.500 11.375
2023-08-09 2023-08-08 4 GILL SIMBA EVLO Common Stock S - Sale D 9,5100 -342 -3 3.754
2023-08-09 2023-08-07 4 GILL SIMBA EVLO Common Stock M - Exercise D 1.171 4.096
2023-08-09 2023-08-08 4 Thorell Marella EVLO Common Stock S - Sale D 9,5100 -2.004 -19 9.069
2023-08-09 2023-08-07 4 Thorell Marella EVLO Common Stock M - Exercise D 6.500 11.073
2023-07-21 3 Horizon Technology Finance Corp EVLO Common Stock D 2.164.502
2023-07-13 2023-07-11 4 Flagship Ventures Fund IV General Partner LLC By Flagship Pioneering Fund VII, L.P. EVLO Common Stock P - Purchase I 2,3100 3.246.753 7.500 3.931.685
2023-07-13 2023-07-11 4 Flagship Ventures Fund IV General Partner LLC By Nutritional Health LTP Fund, L.P. EVLO Common Stock P - Purchase I 2,3100 1.082.251 2.500 1.493.241
2023-07-13 2023-07-11 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Fund IV, L.P. EVLO Common Stock P - Purchase I 2,3100 1.082.251 2.500 1.493.241
2023-06-12 2023-05-23 4 Bodmer Mark EVLO Common Stock S - Sale D 0,1418 -22.571 -3 262.557
2023-05-10 2023-05-08 4 Thorell Marella EVLO Common Stock S - Sale D 0,1255 -38.531 -5 91.469
2023-05-10 2023-05-08 4 Bodmer Mark EVLO Common Stock S - Sale D 0,1255 -68.014 -9 285.128
2023-05-10 2023-05-08 4 GILL SIMBA EVLO Common Stock S - Sale D 0,1255 -3.537 -0 58.512
2023-05-10 2023-05-08 4 McHale Duncan EVLO Common Stock S - Sale D 0,1255 -66.730 -8 97.516
2023-05-09 2023-05-07 4 McHale Duncan EVLO Common Stock M - Exercise D 130.000 164.246
2023-05-09 2023-05-07 4 Bodmer Mark EVLO Common Stock M - Exercise D 132.500 353.142
2023-05-09 2023-05-07 4 GILL SIMBA EVLO Common Stock M - Exercise D 23.437 62.049
2023-05-09 2023-05-07 4 Thorell Marella EVLO Common Stock M - Exercise D 130.000 130.000
2023-02-02 2023-01-31 4 Plinio Mark D. EVLO Common Stock A - Award D 0,8800 1.250 1 3.750
2023-01-23 2023-01-23 4 CARRIERE STEPHEN J EVLO Common Stock S - Sale D 1,0604 -151 -0 203
2023-01-23 2023-01-19 4 CARRIERE STEPHEN J EVLO Common Stock M - Exercise D 354 354
2022-10-14 2022-07-29 4 Plinio Mark D. EVLO Common Stock A - Award D 1,7900 1.250 2 2.500
2022-06-30 2022-06-30 4 Epstein David R EVLO Common Stock M - Exercise D 2.874 93.932
2022-06-30 2022-06-30 4 Epstein David R EVLO Common Stock M - Exercise D 2.053 91.058
2022-06-01 3 Flagship Pioneering Fund VII, L.P. By Flagship Pioneering Fund VII, L.P. EVLO Common Stock I 13.698.630
2022-06-01 2022-05-27 4 Flagship Ventures Fund IV General Partner LLC By Flagship Pioneering Fund VII, L.P. EVLO Common Stock P - Purchase I 1,4600 13.698.630 20.000 13.698.630
2022-06-01 2022-05-27 4 Flagship Ventures Fund IV General Partner LLC By Nutritional Health LTP Fund, L.P. EVLO Common Stock P - Purchase I 1,4600 6.849.315 10.000 8.219.791
2022-06-01 2022-05-27 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Opportunities Fund I, L.P. EVLO Common Stock P - Purchase I 1,4600 1.369.863 2.000 5.495.324
2022-06-01 2022-05-27 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Fund IV-Rx, L.P. EVLO Common Stock P - Purchase I 1,4600 1.095.890 1.600 1.887.419
2022-06-01 2022-05-27 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Fund IV, L.P. EVLO Common Stock P - Purchase I 1,4600 4.383.561 6.400 7.590.873
2022-06-01 2022-05-31 4 Epstein David R EVLO Common Stock M - Exercise D 2.873 89.005
2022-06-01 2022-05-31 4 Epstein David R EVLO Common Stock M - Exercise D 2.052 86.132
2022-05-31 2022-05-27 4 McHale Duncan EVLO Common Stock P - Purchase D 1,4600 34.246 50 34.246
2022-05-31 2022-05-27 4 Darzi Lord Ara EVLO Common Stock P - Purchase D 1,4600 342.465 500 342.465
2022-05-31 2022-05-27 4 Epstein David R EVLO Common Stock P - Purchase D 1,4600 17.123 25 84.080
2022-05-02 2022-05-02 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.873 5.747
2022-05-02 2022-05-02 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.053 4.105
2022-05-02 2022-05-02 4 Epstein David R EVLO Common Stock M - Exercise D 2.873 66.957
2022-05-02 2022-05-02 4 Epstein David R EVLO Common Stock M - Exercise D 2.053 64.084
2022-04-05 2022-04-01 4 Gutierrez-Ramos Jose-Carlos EVLO Stock Option (Right to Buy) A - Award D 3,36 40.000 40.000
2022-04-05 3 Gutierrez-Ramos Jose-Carlos EVLO Common Stock D 10.000
2022-04-05 2022-04-01 4 Williams Tonya EVLO Stock Option (Right to Buy) A - Award D 3,36 40.000 40.000
2022-04-01 2022-03-31 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.874 8.620
2022-04-01 2022-03-31 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.052 6.158
2022-04-01 2022-03-31 4 Epstein David R EVLO Common Stock M - Exercise D 2.874 62.031
2022-04-01 2022-03-31 4 Epstein David R EVLO Common Stock M - Exercise D 2.052 59.157
2022-03-01 2022-02-28 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.873 11.494
2022-03-01 2022-02-28 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.053 8.210
2022-03-01 2022-02-28 4 Epstein David R EVLO Common Stock M - Exercise D 2.873 57.105
2022-03-01 2022-02-28 4 Epstein David R EVLO Common Stock M - Exercise D 2.053 54.232
2022-02-01 2022-01-31 4 Plinio Mark D. EVLO Common Stock A - Award D 4,0035 1.250 5 1.250
2022-01-31 2022-01-31 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.873 14.367
2022-01-31 2022-01-31 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.052 10.263
2022-01-31 2022-01-31 4 Epstein David R EVLO Common Stock M - Exercise D 2.873 52.179
2022-01-31 2022-01-31 4 Epstein David R EVLO Common Stock M - Exercise D 2.052 49.306
2022-01-21 2022-01-19 4 CARRIERE STEPHEN J EVLO Restricted Stock Units A - Award D 0,00 1.417 1.417
2022-01-21 2022-01-19 4 CARRIERE STEPHEN J EVLO Stock Option (Right to Buy) A - Award D 5,05 6.250 6.250
2022-01-21 2022-01-19 4 Char Daniel EVLO Stock Option (Right to Buy) A - Award D 5,05 80.000 80.000
2022-01-21 2022-01-19 4 Plinio Mark D. EVLO Stock Option (Right to Buy) A - Award D 5,05 60.000 60.000
2022-01-21 2022-01-19 4 Zung Jonathan B. EVLO Stock Option (Right to Buy) A - Award D 5,05 115.000 115.000
2022-01-21 2022-01-19 4 McHale Duncan EVLO Stock Option (Right to Buy) A - Award D 5,05 100.000 100.000
2022-01-21 2022-01-19 4 Bodmer Mark EVLO Stock Option (Right to Buy) A - Award D 5,05 125.000 125.000
2022-01-21 2022-01-19 4 Scavo Luca EVLO Stock Option (Right to Buy) A - Award D 5,05 60.000 60.000
2022-01-21 2022-01-19 4 GILL SIMBA EVLO Stock Option (Right to Buy) A - Award D 5,05 300.000 300.000
2022-01-03 2021-12-31 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.874 17.240
2022-01-03 2021-12-31 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.052 12.315
2022-01-03 2021-12-31 4 Epstein David R EVLO Common Stock M - Exercise D 2.874 47.254
2022-01-03 2021-12-31 4 Epstein David R EVLO Common Stock M - Exercise D 2.052 44.380
2021-12-01 2021-11-30 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.873 20.114
2021-12-01 2021-11-30 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.053 14.367
2021-12-01 2021-11-30 4 Epstein David R EVLO Common Stock M - Exercise D 2.873 42.328
2021-12-01 2021-11-30 4 Epstein David R EVLO Common Stock M - Exercise D 2.053 39.455
2021-11-01 2021-11-01 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.873 22.987
2021-11-01 2021-11-01 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.052 16.420
2021-11-01 2021-11-01 4 Epstein David R EVLO Common Stock M - Exercise D 2.873 37.402
2021-11-01 2021-11-01 4 Epstein David R EVLO Common Stock M - Exercise D 2.052 34.529
2021-10-01 2021-10-01 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.874 25.860
2021-10-01 2021-10-01 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -2.053 18.472
2021-10-01 2021-10-01 4 Epstein David R EVLO Common Stock M - Exercise D 2.874 32.477
2021-10-01 2021-10-01 4 Epstein David R EVLO Common Stock M - Exercise D 2.053 29.603
2021-09-07 2021-09-02 4 McInnes Iain B. EVLO Stock Option (Right to Buy) A - Award D 11,26 35.000 35.000
2021-09-03 2021-09-03 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -5.746 28.734
2021-09-03 2021-09-03 4 Epstein David R EVLO Restricted Stock Units M - Exercise D 0,00 -4.104 20.525
2021-09-03 2021-09-03 4 Epstein David R EVLO Common Stock M - Exercise D 5.746 27.550
2021-09-03 2021-09-03 4 Epstein David R EVLO Common Stock M - Exercise D 4.104 21.804
2021-07-02 2021-06-30 4 Epstein David R EVLO Restricted Stock Units A - Award D 0,00 34.480 34.480
2021-07-02 2021-06-30 4 Epstein David R EVLO Restricted Stock Units A - Award D 0,00 24.629 24.629
2021-06-16 2021-06-14 4 Plinio Mark D. EVLO Stock Option (Right to Buy) A - Award D 16,34 250.000 250.000
2021-06-11 2021-06-09 4 MELAS KYRIAZI THEO EVLO Stock Option (Right to Buy) A - Award D 14,19 1.810 1.810
2021-06-11 2021-06-08 4 MELAS KYRIAZI THEO EVLO Stock Option (Right to Buy) A - Award D 14,60 15.690 15.690
2021-06-11 2021-06-09 4 PERRY DAVID P EVLO Stock Option (Right to Buy) A - Award D 14,19 1.810 1.810
2021-06-11 2021-06-08 4 PERRY DAVID P EVLO Stock Option (Right to Buy) A - Award D 14,60 15.690 15.690
2021-06-11 2021-06-09 4 Andres Juan EVLO Stock Option (Right to Buy) A - Award D 14,19 1.810 1.810
2021-06-11 2021-06-08 4 Andres Juan EVLO Stock Option (Right to Buy) A - Award D 14,60 15.690 15.690
2021-06-11 2021-06-09 4 Darzi Lord Ara EVLO Stock Option (Right to Buy) A - Award D 14,19 1.810 1.810
2021-06-11 2021-06-08 4 Darzi Lord Ara EVLO Stock Option (Right to Buy) A - Award D 14,60 15.690 15.690
2021-06-03 2021-06-01 4 Scavo Luca EVLO Restricted Stock Units A - Award D 0,00 4.545 4.545
2021-06-03 2021-06-01 4 Scavo Luca EVLO Stock Option (Right to Buy) A - Award D 14,24 300.000 300.000
2021-04-13 2021-04-09 4 McHugh Julie EVLO Stock Option (Right to Buy) A - Award D 10,04 31.380 31.380
2021-02-04 2021-02-02 4 Flagship Ventures Fund IV General Partner LLC EVLO Common Stock P - Purchase I 15,0000 46.429 696 4.125.461
2021-02-04 2021-02-02 4 Flagship Ventures Fund IV General Partner LLC EVLO Common Stock P - Purchase I 15,0000 37.143 557 1.370.476
2021-02-04 2021-02-02 4 Flagship Ventures Fund IV General Partner LLC EVLO Common Stock P - Purchase I 15,0000 37.143 557 1.370.476
2021-02-04 2021-02-02 4 Flagship Ventures Fund IV General Partner LLC EVLO Common Stock P - Purchase I 15,0000 9.285 139 791.529
2021-01-29 2021-01-27 4 Char Daniel EVLO Stock Option (Right to Buy) A - Award D 16,65 57.000 57.000
2021-01-29 2021-01-27 4 Liu Xiaoli Jacqueline EVLO Restricted Stock Units A - Award D 0,00 5.680 5.680
2021-01-29 2021-01-27 4 Liu Xiaoli Jacqueline EVLO Stock Option (Right to Buy) A - Award D 16,65 24.000 24.000
2021-01-29 2021-01-27 4 McHale Duncan EVLO Stock Option (Right to Buy) A - Award D 16,65 96.500 96.500
2021-01-29 2021-01-27 4 Bodmer Mark EVLO Stock Option (Right to Buy) A - Award D 16,65 179.000 179.000
2021-01-29 2021-01-27 4 Hohneker John EVLO Stock Option (Right to Buy) A - Award D 16,65 31.380 31.380
2021-01-29 2021-01-27 4 GILL SIMBA EVLO Stock Option (Right to Buy) A - Award D 16,65 275.000 275.000
2021-01-29 2021-01-27 4 Zung Jonathan B. EVLO Stock Option (Right to Buy) A - Award D 16,65 300.000 300.000
2020-12-14 2020-12-11 4 Epstein David R EVLO Common Stock P - Purchase D 7,0200 200 1 17.700
2020-12-14 2020-12-11 4 Epstein David R EVLO Common Stock P - Purchase D 6,9800 500 3 17.500
2020-12-14 2020-12-11 4 Epstein David R EVLO Common Stock P - Purchase D 6,9100 1.000 7 17.000
2020-12-14 2020-12-11 4 Epstein David R EVLO Common Stock P - Purchase D 7,1600 800 6 16.000
2020-12-14 2020-12-11 4 Epstein David R EVLO Common Stock P - Purchase D 6,4900 4.970 32 15.200
2020-12-14 2020-12-11 4 Epstein David R EVLO Common Stock P - Purchase D 6,4500 30 0 10.230
2020-12-14 2020-12-11 4 Epstein David R EVLO Common Stock P - Purchase D 6,4000 200 1 10.200
2020-12-02 2020-12-01 4 Liu Xiaoli Jacqueline EVLO Common Stock S - Sale D 5,1700 -3.000 -16 0
2020-10-14 2020-10-11 4 Epstein David R EVLO Stock Option (Right to Buy) A - Award D 5,66 44.743 44.743
2020-10-14 2020-10-11 4 Epstein David R EVLO Stock Option (Right to Buy) A - Award D 5,66 59.395 59.395
2020-09-01 2020-08-31 4 Epstein David R EVLO Common Stock P - Purchase D 4,5800 1.000 5 10.000
2020-09-01 2020-08-31 4 Epstein David R EVLO Common Stock P - Purchase D 4,4800 1.000 4 9.000
2020-09-01 2020-08-31 4 Epstein David R EVLO Common Stock P - Purchase D 4,4700 1.000 4 8.000
2020-09-01 2020-08-31 4 Epstein David R EVLO Common Stock P - Purchase D 4,4600 2.752 12 7.000
2020-09-01 2020-08-28 4 Epstein David R EVLO Common Stock P - Purchase D 4,4000 3.248 14 4.248
2020-09-01 2020-08-28 4 Epstein David R EVLO Common Stock P - Purchase D 4,3400 1.000 4 1.000
2020-07-14 2020-07-10 4 Liu Xiaoli Jacqueline EVLO Stock Option (Right to Buy) A - Award D 4,20 30.000 30.000
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 6.624.607
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 5.312.303
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 6.624.607
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 5.312.303
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 6.624.607
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 5.312.303
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 5.312.303
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 6.624.607
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 5.312.303
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 6.624.607
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 6.624.607
2020-07-01 3 Flagship VentureLabs V Manager LLC EVLO Common Stock I 5.312.303
2020-07-01 2020-06-29 4 Flagship Ventures Fund IV General Partner LLC EVLO Common Stock P - Purchase I 3,7500 1.666.667 6.250 4.079.032
2020-07-01 2020-06-29 4 Flagship Ventures Fund IV General Partner LLC EVLO Common Stock P - Purchase I 3,7500 1.333.333 5.000 1.333.333
2020-07-01 2020-06-29 4 Flagship Ventures Fund IV General Partner LLC EVLO Common Stock P - Purchase I 3,7500 1.333.333 5.000 1.333.333
2020-07-01 2020-06-29 4 Flagship Ventures Fund IV General Partner LLC EVLO Common Stock P - Purchase I 3,7500 333.333 1.250 782.244
2020-06-18 2020-06-17 4 Andres Juan EVLO Stock Option (Right to Buy) A - Award D 3,59 15.690 15.690
2020-06-18 2020-06-17 4 PERRY DAVID P EVLO Stock Option (Right to Buy) A - Award D 3,59 15.690 15.690
2020-06-18 2020-06-17 4 Darzi Lord Ara EVLO Stock Option (Right to Buy) A - Award D 3,59 15.690 15.690
2020-06-18 2020-06-17 4 MELAS KYRIAZI THEO EVLO Stock Option (Right to Buy) A - Award D 3,59 15.690 15.690
2020-06-18 2020-06-17 4 Simonian Nancy A EVLO Stock Option (Right to Buy) A - Award D 3,59 15.690 15.690
2020-04-10 2020-04-08 4 Graham Neil EVLO Stock Option (Right to Buy) A - Award D 3,72 150.000 150.000
2020-03-02 3 Liu Xiaoli Jacqueline EVLO Common Stock D 6.000
2020-03-02 3 Liu Xiaoli Jacqueline EVLO Common Stock D 6.000
2020-03-02 3 Liu Xiaoli Jacqueline EVLO Common Stock D 6.000
2020-01-30 2020-01-28 4 Poole Jonathan EVLO Stock Option (Right to Buy) A - Award D 7,06 48.000 48.000
2020-01-30 2020-01-28 4 Poole Jonathan EVLO Stock Option (Right to Buy) A - Award D 7,06 106.000 106.000
2020-01-30 2020-01-28 4 GILL SIMBA EVLO Stock Option (Right to Buy) A - Award D 7,06 250.000 250.000
2020-01-30 2020-01-28 4 Bodmer Mark EVLO Stock Option (Right to Buy) A - Award D 7,06 100.000 100.000
2020-01-30 2020-01-28 4 Char Daniel EVLO Stock Option (Right to Buy) A - Award D 7,06 35.000 35.000
2020-01-30 2020-01-28 4 McHale Duncan EVLO Stock Option (Right to Buy) A - Award D 7,06 117.000 117.000
2019-12-06 2019-12-04 4 Andres Juan EVLO Stock Option (Right to Buy) A - Award D 4,44 31.380 31.380
2019-09-17 2019-09-14 4 Epstein David R EVLO Stock Option (Right to Buy) A - Award D 7,93 75.000 75.000
2019-09-17 2019-09-14 4 Epstein David R EVLO Stock Option (Right to Buy) A - Award D 7,93 75.000 75.000
2019-06-14 2019-06-12 4 Gutierrez-Ramos Jose-Carlos EVLO Stock Option (Right to Buy) A - Award D 7,07 31.380 31.380
2019-06-13 2019-06-12 4 AFEYAN NOUBAR EVLO Stock Option (Right to Buy) A - Award D 7,07 15.690 15.690
2019-06-13 2019-06-12 4 Epstein David R EVLO Stock Option (Right to Buy) A - Award D 7,07 15.690 15.690
2019-06-13 2019-06-12 4 PERRY DAVID P EVLO Stock Option (Right to Buy) A - Award D 7,07 15.690 15.690
2019-06-13 2019-06-12 4 Simonian Nancy A EVLO Stock Option (Right to Buy) A - Award D 7,07 15.690 15.690
2019-06-13 2019-06-12 4 Darzi Lord Ara EVLO Stock Option (Right to Buy) A - Award D 7,07 15.690 15.690
2019-06-13 2019-06-12 4 MELAS KYRIAZI THEO EVLO Stock Option (Right to Buy) A - Award D 7,07 15.690 15.690
2019-01-16 2019-01-14 4 Bodmer Mark EVLO Stock Option (Right to Buy) A - Award D 13,71 100.000 100.000
2019-01-16 2019-01-14 4 Poole Jonathan EVLO Stock Option (Right to Buy) A - Award D 13,71 100.000 100.000
2019-01-16 2019-01-14 4 GILL SIMBA EVLO Stock Option (Right to Buy) A - Award D 13,71 220.000 220.000
2018-11-01 2018-10-31 4 Char Daniel EVLO Stock Option A - Award D 9,11 100.000 100.000
2018-05-21 2018-05-11 4 Alexandria Venture Investments, LLC EVLO Series C preferred stock C - Conversion D -619.195 0
2018-05-21 2018-05-11 4 Alexandria Venture Investments, LLC EVLO Series B preferred stock C - Conversion D -1.388.889 0
2018-05-21 2018-05-11 4 Alexandria Venture Investments, LLC EVLO Series A-3 preferred stock C - Conversion D -416.650 0
2018-05-21 2018-05-11 4 Alexandria Venture Investments, LLC EVLO Common Stock C - Conversion D 594.443 594.443
2018-05-15 2018-05-11 4 Flagship Ventures Fund V General Partner LLC See footnotes EVLO Series C Preferred Stock C - Conversion I -4.643.963 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund V General Partner LLC See footnotes EVLO Series B Preferred Stock C - Conversion I -18.611.110 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund V General Partner LLC See footnotes EVLO Series A-3 Preferred Stock C - Conversion I -8.333.000 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund V General Partner LLC See footnotes EVLO Series A-2 Preferred Stock C - Conversion I -5.416.667 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund V General Partner LLC See footnotes EVLO Series A-1 Preferred Stock C - Conversion I -10.102.055 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund V General Partner LLC See footnotes EVLO Series A Preferred Stock C - Conversion I -12.536.945 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund V General Partner LLC See footnotes EVLO Common Stock P - Purchase I 16,0000 281.250 4.500 18.233.403
2018-05-15 2018-05-11 4 Flagship Ventures Fund V General Partner LLC See footnotes EVLO Common Stock C - Conversion I 14.622.143 17.952.153
2018-05-15 2018-05-11 4 Flagship Ventures Fund IV General Partner LLC See footnotes EVLO Series C Preferred Stock C - Conversion I -4.643.963 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund IV General Partner LLC See footnotes EVLO Series B Preferred Stock C - Conversion I -18.611.110 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund IV General Partner LLC See footnotes EVLO Series A-3 Preferred Stock C - Conversion I -8.333.000 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund IV General Partner LLC See footnotes EVLO Series A-2 Preferred Stock C - Conversion I -5.416.667 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund IV General Partner LLC See footnotes EVLO Series A-1 Preferred Stock C - Conversion I -10.102.055 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund IV General Partner LLC See footnotes EVLO Series A Preferred Stock C - Conversion I -12.536.945 0
2018-05-15 2018-05-11 4 Flagship Ventures Fund IV General Partner LLC See footnotes EVLO Common Stock P - Purchase I 16,0000 281.250 4.500 18.233.403
2018-05-15 2018-05-11 4 Flagship Ventures Fund IV General Partner LLC See footnotes EVLO Common Stock C - Conversion I 14.622.143 17.952.153
2018-05-10 2018-05-08 4 Simonian Nancy A EVLO Stock Option A - Award D 16,00 31.380 31.380
2018-05-10 2018-05-08 4 Bodmer Mark EVLO Stock Option A - Award D 16,00 55.437 55.437
2018-05-10 2018-05-08 4 McHale Duncan EVLO Stock Option A - Award D 16,00 79.052 79.052
2018-05-10 2018-05-08 4 GILL SIMBA EVLO Stock Option A - Award D 16,00 145.869 145.869
2018-05-10 2018-05-08 4 Poole Jonathan EVLO Stock Option A - Award D 16,00 71.497 71.497
2018-05-08 3 Flagship Ventures Fund IV-Rx, L.P. See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 Flagship Ventures Fund IV-Rx, L.P. See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 Flagship Ventures Fund IV-Rx, L.P. See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 Flagship Ventures Fund IV-Rx, L.P. See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 Flagship Ventures Fund IV-Rx, L.P. See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 Flagship Ventures Fund IV-Rx, L.P. See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 KANIA EDWIN M JR See footnotes EVLO Common Stock I 6.660.018
2018-05-08 3 GILL SIMBA EVLO Common Stock D 77.224
2018-05-08 3 GILL SIMBA EVLO Common Stock D 77.224
2018-05-08 3 GILL SIMBA EVLO Common Stock D 77.224
2018-05-08 3 Bodmer Mark EVLO Common Stock D 441.284
2018-05-08 3 Bodmer Mark EVLO Common Stock D 441.284
2018-05-08 3 Bodmer Mark EVLO Common Stock D 441.284
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista